Swedbank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Swedbank's DGX Position: Q3 2026 in Review
Swedbank increased its Quest Diagnostics (DGX) stake by 0.46% in Q3 2026, buying an estimated $104K and bringing the position to 98,039 shares worth $22.8M. The position accounts for 0.02% of the portfolio, ranked #360.
Swedbank first reported a position in DGX in Q1 2021 and has held it in 23 quarters since. The position peaked at $24.4M in Q3 2021. 605 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Swedbank held 98,039 shares of Quest Diagnostics worth $22.8M as of Q3 2026.
- Swedbank bought 451 Quest Diagnostics shares in Q3 2026, an estimated $104K.
- Quest Diagnostics made up 0.02% of Swedbank's portfolio in Q3 2026, its #360 holding.
- Swedbank first reported a position in Quest Diagnostics in Q1 2021 and has held it in 23 quarters since.
- Swedbank's Quest Diagnostics position peaked at $24.4M in Q3 2021.
- 605 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.